| # | Drug | Count |
|---|---|---|
| 0 | DUPILUMAB | 71 |
| 1 | ARIPIPRAZOLE | 27 |
| 2 | ESTRADIOL | 19 |
| 3 | METHYLPHENIDATE HYDROCHLORIDE | 18 |
| 4 | ADALIMUMAB | 17 |
| 5 | PROGESTERONE | 17 |
| 6 | SPIRONOLACTONE | 15 |
| 7 | ESTRADIOL GEL 0.1% | 14 |
| 8 | ESTRADIOL TRANSDERMAL | 14 |
| 9 | ESTRADIOL, | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROTRIPTYLINE HYDROCHLORIDE | 1 | 0.0104 |
| 1 | MINERAL OIL AND WHITE PETROLATUM | 2 | 0.0039 |
| 2 | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | 1 | 0.0032 |
| 3 | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0022 |
| 4 | FLUOROMETHOLONE | 6 | 0.0018 |
| 5 | POLYETHYLENE GLYCOL 400 AND PROPYLENE GLYCOL | 2 | 0.0018 |
| 6 | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | 1 | 0.0018 |
| 7 | PYRITHIONE ZINC | 1 | 0.0016 |
| 8 | ESTRADIOL VALERATE | 1 | 0.0013 |
| 9 | TROPICAMIDE | 2 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interleukin-4 Receptor alpha Antagonist [EPC] | 71 |
| 1 | Corticosteroid [EPC] | 39 |
| 2 | Atypical Antipsychotic [EPC] | 28 |
| 3 | Estrogen [EPC] | 20 |
| 4 | Progesterone [EPC] | 17 |
| 5 | Aldosterone Antagonist [EPC] | 15 |
| 6 | Central Nervous System Stimulant [EPC] | 15 |
| 7 | Retinoid [EPC] | 15 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 12 |
| 9 | Tumor Necrosis Factor Blocker [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progesterone [EPC] | 17 | 0.0007 |
| 1 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Ectoparasiticide [EPC] | 1 | 0.0003 |
| 3 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 4 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 5 | Anticholinergic [EPC] | 3 | 0.0002 |
| 6 | Central Nervous System Stimulant [EPC] | 15 | 0.0002 |
| 7 | Interleukin-4 Receptor alpha Antagonist [EPC] | 71 | 0.0001 |
| 8 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 2 | 0.0001 |